Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.
GlaxoSmithKline, DMPK Projects, Ware, United Kingdom.
J Pharm Sci. 2020 Sep;109(9):2891-2901. doi: 10.1016/j.xphs.2020.05.026. Epub 2020 Jun 3.
Lysosomes are acidic intracellular organelles that can extensively sequester basic lipophilic drugs due to pH and membrane partitioning, and therefore may significantly influence subcellular drug concentrations. Current in vitro methods for lysosomal drug sequestration evaluation typically lack the ability to accurately and sensitively quantify drug concentrations directly within the lysosome. In the current study, magnetic lysosomal isolation was used in the lysosome rich rat NR8383 cell line and combined with LC-MS/MS analysis to quantify intralysosomal concentrations and lysosomal partitioning (Kp) values of imipramine. The purity of the isolated lysosomes was validated by enzymatic and electron microscopy analysis. Lysosomal imipramine accumulation was explored using 2 methods: addition of imipramine to cells followed by lysosomal isolation (Method 1), and direct addition of imipramine to isolated lysosomes (Method 2). This work highlighted that both experimental buffers and ATP influence intralysosomal drug concentrations, and non-specific drug binding and re-distribution limits the use of Method 1. Method 2 may benefit future lysosomal drug accumulation studies, as imipramine demonstrated high Kp values (3500), comparable to in silico predictions. This study reports a novel method for the direct quantification of intralysosomal drug concentrations that has the ability to be adapted to other cell types.
溶酶体是酸性的细胞内细胞器,由于 pH 值和膜分配,可广泛隔离碱性亲脂性药物,因此可能会显著影响细胞内药物浓度。目前用于溶酶体药物隔离评估的体外方法通常缺乏直接在溶酶体内准确和敏感地定量药物浓度的能力。在本研究中,使用磁性溶酶体分离在富含溶酶体的大鼠 NR8383 细胞系中,并与 LC-MS/MS 分析相结合,定量测定了阿米替林的溶酶体内浓度和溶酶体分配系数(Kp)值。通过酶和电子显微镜分析验证了分离的溶酶体的纯度。使用 2 种方法探索了溶酶体中阿米替林的积累:将阿米替林加入细胞后进行溶酶体分离(方法 1),以及直接将阿米替林加入分离的溶酶体(方法 2)。这项工作强调了实验缓冲液和 ATP 都会影响溶酶体内的药物浓度,而非特异性药物结合和再分配限制了方法 1 的使用。方法 2 可能有益于未来的溶酶体药物积累研究,因为阿米替林表现出高 Kp 值(3500),与计算机预测相当。本研究报告了一种直接定量溶酶体内药物浓度的新方法,该方法具有适应其他细胞类型的能力。